IRP
AMGN icon

Investment Research Partners’s Amgen AMGN Stock Holding History

Investment Research Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
3,890
+224
+6% +$76.7K 0.48% 41
2026
Q1 		$1.29M Sell
3,666
-42
-1% -$15K 0.52% 40
2025
Q4 		$1.21M Buy
3,708
+75
+2% +$23.8K 0.52% 42
2025
Q3 		$1.06M Buy
+3,633
New +$1.05M 0.48% 48

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Investment Research Partners's AMGN Position: Q2 2026 in Review

Investment Research Partners increased its Amgen (AMGN) stake by 6.1% in Q2 2026, buying an estimated $76.7K and bringing the position to 3,890 shares worth $1.41M. The position accounts for 0.48% of the portfolio, ranked #41.

Investment Research Partners first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 2,557 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Investment Research Partners held 3,890 shares of Amgen worth $1.41M as of Q2 2026.
  • Investment Research Partners bought 224 Amgen shares in Q2 2026, an estimated $76.7K.
  • Amgen made up 0.48% of Investment Research Partners's portfolio in Q2 2026, its #41 holding.
  • Investment Research Partners first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 2,557 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.